Epsilon Healthcare (ASX:EPN) Total Operating Expense: A$8.14 Mil (TTM As of Dec. 2025)


What is Epsilon Healthcare Total Operating Expense?

Epsilon Healthcare ASX:EPN Total Operating Expense is A$8.14 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Epsilon Healthcare's Total Operating Expense for the six months ended in Dec. 2025 was A$4.16 Mil. Epsilon Healthcare's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$8.14 Mil.

Epsilon Healthcare Total Operating Expense Related Terms

Epsilon Healthcare Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Epsilon Healthcare's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epsilon Healthcare Total Operating Expense Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 11.22 9.11 7.40 9.21 8.14

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.33 3.87 5.35 3.97 4.16

Epsilon Healthcare Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$8.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of A$8.14 Mil mean?
Epsilon Healthcare (ASX:EPN) has a Total Operating Expense of A$8.14 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Epsilon Healthcare and its competitors.
Is Epsilon Healthcare's Total Operating Expense too high?
Epsilon Healthcare's current Total Operating Expense is A$8.14 Mil.
How does Epsilon Healthcare's Total Operating Expense compare to ZTS and UTHR?
Epsilon Healthcare's Total Operating Expense of A$8.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Epsilon Healthcare and its competitors. Epsilon Healthcare's current Total Operating Expense is A$8.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epsilon Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Epsilon Healthcare (ASX:EPN) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.02 — trading 26.7% below its estimated fair value. The current Total Operating Expense is A$8.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Epsilon Healthcare (ASX:EPN), the current Total Operating Expense is A$8.14 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epsilon Healthcare Business Description

Address 5 Goodyear Street, Southport, QLD, AUS, 4215
Epsilon Healthcare Ltd is an Australian based, globally active healthcare organisation. It operates a diversified and vertically integrated portfolio of assets, including healthcare and clinics operation, pharmaceutical contract development and manufacturing operation & pharmacy services. The company offers end-to-end solutions across the healthcare spectrum: from product development and manufacturing to patient care. The company's three (3) main operating segments are: a. Contract Development and Manufacturing activities, b. Telehealth medical practice services; and c. Pharmacy services. The majority of revenue is derived from the Contract Development and Manufacturing activities segment.